PT-141 (Bremelanotide)
PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied for effects on sexual desire and arousal pathways. Unlike compounds framed around blood flow alone, PT-141 is usually discussed as working centrally through neurobehavioral signaling.
Disclaimer: Not medical advice. Consult a practitioner.
Mechanism overview
PT-141 acts primarily through melanocortin receptor pathways in the central nervous system. In practical terms, that means it is usually described as influencing desire and arousal signaling rather than serving as a direct vasodilator. This makes it distinct from erectile-function drugs that work mainly through peripheral hemodynamic pathways.
Conditions and use-cases researched for
- Hypoactive sexual desire context
- Female sexual interest / arousal research
- Male sexual function discussions in some literature and practice settings
- Central arousal pathway research
Evidence notes
PT-141 sits on firmer footing than many gray-market peptides because bremelanotide has formal drug-development and regulatory history. That said, any use discussion still needs context around indication, formulation, adverse effects, and patient selection. It should not be framed casually.
General literature range note
Published literature and approved-product discussions commonly describe PT-141 in milligram-range administration contexts. This page avoids protocol guidance and is for educational reference only.
Safety and practical context
- Nausea is one of the better-known tolerability issues in PT-141 discussions.
- Blood pressure and cardiovascular context may matter depending on the patient.
- Sexual dysfunction can reflect hormonal, vascular, relational, psychological, medication-related, or systemic medical causes.
- A practitioner evaluation is more useful than self-experimentation based on marketing language.
Vendor listing for PT-141
Interested in being listed as a verified PT-141 / bremelanotide supplier? Listings start at $29 for basic exposure. Featured suppliers get homepage visibility and category placement.